Chemcrux FY26 Net Profit Rises 30% to INR 544.97 Lacs; Board Approves Section 8 Subsidiary
Chemcrux Enterprises reported a 30.1% rise in FY26 standalone net profit to INR 544.97 lacs, with revenue from operations growing to INR 8,257.92 lacs. The Board recommended a 10% final dividend for FY26 and approved the incorporation of a Section 8 non-profit wholly-owned subsidiary to fulfill CSR obligations, subject to MCA and regulatory approvals.
*this image is generated using AI for illustrative purposes only.
Chemcrux Enterprises Limited reported its audited standalone and consolidated financial results for the quarter and year ended 31st March 2026. The Board of Directors convened a meeting on 14th May 2026 to approve the results, recommend a final dividend, and approve the incorporation of a non-profit wholly-owned subsidiary under Section 8 of the Companies Act, 2013. The board meeting commenced at 11:30 A.M. and concluded at 04:10 P.M.
Financial Performance
For the financial year ended 31st March 2026, the company reported a standalone net profit of INR 544.97 lacs, an increase of 30.1% compared to INR 418.86 lacs in the previous year. Revenue from operations for the year stood at INR 8,257.92 lacs, up from INR 7,025.39 lacs in the prior year. For the quarter ended 31st March 2026, net profit was INR 198.68 lacs.
On a consolidated basis, net profit for the year was INR 373.08 lacs, compared to INR 391.30 lacs in the previous year. Total consolidated revenue for FY26 was INR 8,267.13 lacs. The company's subsidiary, Kalichem Private Limited, became a wholly-owned subsidiary during the year following the acquisition of the remaining 50% stake in February 2025.
The following table summarizes the standalone financial performance for the year:
| Parameter: | Year Ended 31st March 2026 (INR Lacs) | Year Ended 31st March 2025 (INR Lacs) |
|---|---|---|
| Revenue from Operations: | 8,257.92 | 7,025.39 |
| Total Income: | 8,525.25 | 7,178.35 |
| Total Expenses: | 7,804.36 | 6,595.54 |
| Profit Before Tax: | 720.89 | 582.81 |
| Net Profit: | 544.97 | 418.86 |
| Earnings Per Share (Basic): | 3.68 | 2.83 |
The statutory auditors, M/s Naresh & Co., Chartered Accountants, issued an unmodified opinion on the audited standalone and consolidated financial statements.
Dividend Declaration
The Board of Directors recommended a final dividend of 10% (Re. 1/- per share) on equity shares of Rs. 10/- each for the financial year 2025-26. This dividend is subject to the approval of shareholders at the ensuing Annual General Meeting.
Section 8 Subsidiary Incorporation
The Board also approved the incorporation of a non-profit making company under Section 8 of the Companies Act, 2013 as a wholly-owned subsidiary of Chemcrux Enterprises. The proposed subsidiary is intended to fulfill the company's CSR obligations and will operate with objects including promotion of commerce, art, science, sports, education, research, social welfare, healthcare, charity, and protection of environment, among other activities enumerated in Schedule VII of the Companies Act, 2013.
The key details of the proposed subsidiary are summarized below:
| Parameter: | Details |
|---|---|
| Entity Type: | Section 8 Company (Non-Profit) |
| Proposed Authorised & Paid-up Share Capital: | Rs. 1,00,000 |
| Shareholding: | 100% (Wholly-Owned Subsidiary) |
| Consideration: | Cash |
| Purpose: | CSR obligation fulfillment |
| Regulatory Approvals Required: | MCA and other relevant statutory/regulatory authorities |
The name of the proposed wholly-owned subsidiary will be as approved by the Ministry of Corporate Affairs, Government of India, and a further update will be provided once the subsidiary is incorporated. The incorporation is subject to MCA and other applicable regulatory approvals, and no indicative timeline has been specified pending those approvals. Upon incorporation, the proposed wholly-owned subsidiary will be treated as a related party of the company.
Historical Stock Returns for Chemcrux Enterprises
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.62% | -2.58% | +0.94% | -21.98% | -38.48% | -12.26% |
How will the full integration of Kalichem Private Limited as a wholly-owned subsidiary impact Chemcrux's consolidated profitability in FY27, given that consolidated net profit declined despite strong standalone growth?
What specific CSR projects or initiatives is Chemcrux planning to undertake through the proposed Section 8 subsidiary, and how will the annual CSR budget be determined going forward?
Could Chemcrux's revenue growth momentum of ~17.5% in FY26 be sustained in FY27, and which product segments or geographies are expected to be the primary growth drivers?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
